Guliz T. Barut

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Adapted Live SARS-CoV-2 Vaccine Elicits Rapid Mucosal Immunity, Protects From Disease, and Reduces Shedding of XBB.1.5.

Adapted Live SARS-CoV-2 Vaccine Elicits Rapid Mucosal Immunity, Protects From Disease, and Reduces Shedding of XBB.1.5.

Journal: European journal of immunology
Published: October 13, 2025

Stress granules formed during infections with RNA viruses have significant virus-specific differences in generation and composition.

Stress granules formed during infections with RNA viruses have significant virus-specific differences in generation and composition.

Journal: PLoS biology
Published: August 01, 2025

Live attenuated SARS-CoV-2 vaccine OTS-228 demonstrates efficacy, safety, and stability in preclinical model.

Live attenuated SARS-CoV-2 vaccine OTS-228 demonstrates efficacy, safety, and stability in preclinical model.

Journal: NPJ vaccines
Published: December 11, 2024

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories.

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories.

Journal: Viruses
Published: November 12, 2024

Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.

Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.

Journal: Swiss medical weekly
Published: August 13, 2024

An RNA replicon system to investigate promising inhibitors of feline coronavirus.

An RNA replicon system to investigate promising inhibitors of feline coronavirus.

Journal: Journal of virology
Published: January 18, 2024

SARS-CoV-2 biology and host interactions.

SARS-CoV-2 biology and host interactions.

Journal: Nature reviews. Microbiology
Published: December 01, 2023

A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications.

A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications.

Journal: Nature microbiology
Published: July 25, 2023

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation.

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation.

Journal: Bone marrow transplantation
Published: December 07, 2022

Single-cell transcriptomics reveals striking heterogeneity and functional organization of dendritic and monocytic cells in the bovine mesenteric lymph node.

Single-cell transcriptomics reveals striking heterogeneity and functional organization of dendritic and monocytic cells in the bovine mesenteric lymph node.

Journal: Frontiers in immunology
Published: November 15, 2022

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.

Journal: Nature communications
Published: May 11, 2022

A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice.

A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice.

Journal: Frontiers in immunology
Published: April 05, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026